1. Home
  2. HIPO vs AVXL Comparison

HIPO vs AVXL Comparison

Compare HIPO & AVXL Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • HIPO
  • AVXL
  • Stock Information
  • Founded
  • HIPO 2015
  • AVXL 2004
  • Country
  • HIPO United States
  • AVXL United States
  • Employees
  • HIPO N/A
  • AVXL N/A
  • Industry
  • HIPO Property-Casualty Insurers
  • AVXL Biotechnology: Biological Products (No Diagnostic Substances)
  • Sector
  • HIPO Finance
  • AVXL Health Care
  • Exchange
  • HIPO Nasdaq
  • AVXL Nasdaq
  • Market Cap
  • HIPO 923.0M
  • AVXL 956.7M
  • IPO Year
  • HIPO N/A
  • AVXL N/A
  • Fundamental
  • Price
  • HIPO $36.78
  • AVXL $7.97
  • Analyst Decision
  • HIPO Strong Buy
  • AVXL Strong Buy
  • Analyst Count
  • HIPO 5
  • AVXL 3
  • Target Price
  • HIPO $35.40
  • AVXL $44.00
  • AVG Volume (30 Days)
  • HIPO 110.3K
  • AVXL 1.3M
  • Earning Date
  • HIPO 11-05-2025
  • AVXL 08-12-2025
  • Dividend Yield
  • HIPO N/A
  • AVXL N/A
  • EPS Growth
  • HIPO N/A
  • AVXL N/A
  • EPS
  • HIPO N/A
  • AVXL N/A
  • Revenue
  • HIPO $425,000,000.00
  • AVXL N/A
  • Revenue This Year
  • HIPO $27.93
  • AVXL N/A
  • Revenue Next Year
  • HIPO $22.04
  • AVXL N/A
  • P/E Ratio
  • HIPO N/A
  • AVXL N/A
  • Revenue Growth
  • HIPO 43.15
  • AVXL N/A
  • 52 Week Low
  • HIPO $19.51
  • AVXL $5.87
  • 52 Week High
  • HIPO $38.98
  • AVXL $14.44
  • Technical
  • Relative Strength Index (RSI)
  • HIPO 56.14
  • AVXL 33.58
  • Support Level
  • HIPO $36.39
  • AVXL $7.88
  • Resistance Level
  • HIPO $37.93
  • AVXL $8.35
  • Average True Range (ATR)
  • HIPO 1.23
  • AVXL 0.46
  • MACD
  • HIPO 0.13
  • AVXL -0.12
  • Stochastic Oscillator
  • HIPO 73.06
  • AVXL 7.27

About HIPO Hippo Holdings Inc.

Hippo Holdings Inc is a home insurance group that created a new standard of care and protection for homeowners. It provides insurance for computers, home offices, electronics, appliances, water backup, and service line coverage, among others. It has three reportable segments Services segment earns fees and commission income without assuming underwriting risk or need for reinsurance, Insurance-as-a-Service managed through the company's subsidiary Spinnaker is a platform to support third-party MGAs, and the Hippo Home Insurance Program engaged in homeowners insurance business. It generates the majority of its revenue from the Insurance-as-a-Service segment.

About AVXL Anavex Life Sciences Corp.

Anavex Life Sciences Corp is a clinical-stage biopharmaceutical company engaged in the development of differentiated therapeutics by applying precision medicine to central nervous system diseases with high unmet need. It analyzes genomic data from clinical studies to identify biomarkers, which are further used in the analysis of clinical trials. The company's focus is on developing treatments for Alzheimer's disease, Parkinson's disease, schizophrenia, neurodevelopmental, neurodegenerative, and rare diseases, including Rett syndrome, and other central nervous system (CNS) disorders. Its various therapeutic candidates in different stages of development include Anavex 2-73 (Blacamesine), Anavex 3-71 (AF710B), Anavex 1-41, and Anavex 1066.

Share on Social Networks: